Neurocrine Biosciences Inc (NASDAQ:NBIX)

79.40
Delayed Data
As of Apr 20
 +1.22 / +1.56%
Today’s Change
41.76
Today|||52-Week Range
92.98
+2.33%
Year-to-Date

Stock Price Forecast

The 11 analysts offering 12-month price forecasts for Neurocrine Biosciences Inc have a median target of 101.00, with a high estimate of 139.00 and a low estimate of 84.00. The median estimate represents a +27.20% increase from the last price of 79.40.

Analyst Recommendations

The current consensus among 12 polled investment analysts is to Buy stock in Neurocrine Biosciences Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.18
Sales
$63.5M
Reporting Date
May 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -357.14%
 
 
 
 
 
 
Growthannually 88.64%
 
 
 
 
 
 

Sales

Growthquarterly -32.81%
 
 
 
 
 
 
Growthannually 134.40%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.